Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
EGFR wild-type + ALK wild-type
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor, NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Associations
(6)
News
Trials
C2 | Sensitive
C3 | Sensitive
C4 | Sensitive
C2 | Resistant
C3 | Resistant
C4 | Resistant
Show legend
Drug categories
Tyrosine Kinase Inhibitors
EGFR
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Non Small Cell Lung Cancer
Lung Adenocarcinoma
rivoceranib
C2
EGFR wild-type + ALK wild-type
|
Non Small Cell Lung Cancer
|
rivoceranib
C4
EGFR wild-type + ALK wild-type
|
Lung Adenocarcinoma
|
rivoceranib
SI-B001
C2
EGFR wild-type + ALK wild-type
|
Non Small Cell Lung Cancer
|
SI-B001
pembrolizumab
C2
EGFR wild-type + ALK wild-type
|
Non Small Cell Lung Cancer
|
pembrolizumab
toripalimab-tpzi
C3
EGFR wild-type + ALK wild-type
|
Non Small Cell Lung Cancer
|
toripalimab-tpzi
anlotinib
C3
EGFR wild-type + ALK wild-type
|
Non Small Cell Lung Cancer
|
anlotinib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login